{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:05:33Z","timestamp":1776287133956,"version":"3.50.1"},"reference-count":45,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Thorac Cardiovasc Surg","ATCS"],"published-print":{"date-parts":[[2011]]},"DOI":"10.5761\/atcs.ra.11.01676","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T06:48:07Z","timestamp":1308552487000},"page":"221-228","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of T4 Esophageal Cancer. Definitive Chemo-Radiotherapy vs Chemo-Radiotherapy Followed by Surgery"],"prefix":"10.5761","volume":"17","author":[{"given":"Tomoki","family":"Makino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1)Gamliel Z, Krasna MJ. Multimodality treatment of esophageal cancer. Surg Clin North Am 2005; 85: 621-30.","DOI":"10.1016\/j.suc.2005.01.011"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0462-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003; 133: 24-31.","DOI":"10.1067\/msy.2003.31"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4)Ichiyoshi Y, Kawahara H, Taga S, Yoshino I, Ohsaki T, et al. Indications and operative techniques for combined aortoesophageal resection. Jpn J Thorac Cardiovasc Surg 1999; 47: 318-24.","DOI":"10.1007\/BF03218018"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5)Shenfine J, McNamee P, Steen N, Bond J, Griffin SM. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005; 9: iii, 1-121.","DOI":"10.3310\/hta9050"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.2739\/kurumemedj.39.183"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Ancona E, Ruol A, Castoro C, Chiarion-Sileni V, Merigliano S, et al. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. Ann Surg 1997; 226: 714-23.","DOI":"10.1097\/00000658-199712000-00008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, et al. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989; 63: 2397-403.","DOI":"10.1002\/1097-0142(19890615)63:12<2397::AID-CNCR2820631204>3.0.CO;2-S"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Tsujinaka T, Shiozaki H, Yamamoto M, Inoue M, Yano M, et al. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg 1999; 177: 503-6.","DOI":"10.1016\/S0002-9610(99)00103-8"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00479.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11)Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Matono S, et al. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 2005; 29: 25-30.","DOI":"10.1007\/s00268-004-7590-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12)de Manzoni G, Pedrazzani C, Pasini F, Bernini M, Minicozzi AM, et al. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol 2007; 95: 261-6.","DOI":"10.1002\/jso.20640"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13)Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, et al. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer. J Surg Oncol 2009; 99: 302-6.","DOI":"10.1002\/jso.21235"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14)Noguchi T, Moriyama H, Wada S, Takeno S, Wakisaka M, et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 2003; 16: 94-8.","DOI":"10.1046\/j.1442-2050.2003.00304.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Ikeda K, Ishida K, Sato N, Koeda K, Aoki K, et al. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus 2001; 14: 197-201.","DOI":"10.1046\/j.1442-2050.2001.00184.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16)Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol 1999; 70: 25-32.","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<25::AID-JSO5>3.0.CO;2-M"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Font A, Arellano A, Fern&aacute;ndez-Llamazares J, Casas D, Boix J, et al. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer. Clin Transl Oncol 2007; 9: 177-82.","DOI":"10.1007\/s12094-007-0032-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 2004; 90: 70-5.","DOI":"10.1038\/sj.bjc.6601461"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600684"},{"issue":"5","key":"20","first-page":"231","volume":"19","author":"ITOH Y","year":"2001","ISSN":"https:\/\/id.crossref.org\/issn\/0288-2043","issn-type":"print"},{"issue":"9","key":"21","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","volume":"17","author":"OHTSU A","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0732-183X","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22)Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, et al. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002; 53: 134-9.","DOI":"10.1016\/S0360-3016(01)02813-9"},{"key":"23","unstructured":"23)The National Cancer Center Institute Common Toxicity Criteria version 2.0."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24)Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, et al. Advanced esophageal carcinoma. World J Surg 1994; 18: 379-87.","DOI":"10.1007\/BF00316818"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25)Junginger T, Dutkowski P. Selective approach to the treatment of oesophageal cancer. Br J Surg 1996; 83: 1473-7.","DOI":"10.1002\/bjs.1800831047"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26)H&ouml;lscher AH, Bollschweiler E, Bumm R, Bartels H, H&ouml;fler H, et al. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845-55.","DOI":"10.1016\/S0039-6060(05)80275-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27)Fok M, Law SY, Wong J. Operable esophageal carcinoma: current results from Hong Kong. World J Surg 1994; 18: 355-60.","DOI":"10.1007\/BF00316814"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28)Matsubara T, Ueda M, Kokudo N, Takahashi T, Muto T, et al. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 2001; 25: 279-84.","DOI":"10.1007\/s002680020060"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29)Higuchi I, Yasuda T, Yano M, Doki Y, Miyata H, et al. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2008; 136: 205-12, 212. e1-3.","DOI":"10.1016\/j.jtcvs.2008.02.016"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30)Vallb&ouml;hmer D, H&ouml;lscher AH, Dietlein M, Bollschweiler E, Baldus SE, et al. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2009; 250: 888-94.","DOI":"10.1097\/SLA.0b013e3181bc9c0d"},{"issue":"24","key":"31","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"1","key":"32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.1997.15.1.277","volume":"15","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0732-183X","issn-type":"print"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00232-6"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34)Ishida K, Iizuka T, Ando N, Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Jpn J Clin Oncol 1996; 26: 310-5.","DOI":"10.1093\/oxfordjournals.jjco.a023238"},{"key":"35","unstructured":"35)Roussel A CS, Jacob JH. Radiation therapy in esophagal carcinoma with broncho-tracheal involvement (BTI): The center Francois Baclesse (CFB) experience. Proc Am Soc Clin Oncol 1995; 14: 190a. (Abstract)."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36)Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)\/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 2004; 34: 615-9.","DOI":"10.1093\/jjco\/hyh107"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37)Yamada S, Takai Y, Ogawa Y, Kakuto Y, Sakamoto K. Radiotherapy for malignant fistula to other tract. Cancer 1989; 64: 1026-8.","DOI":"10.1002\/1097-0142(19890901)64:5<1026::AID-CNCR2820640510>3.0.CO;2-B"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38)Malik SM, Krasnow SH, Wadleigh RG. Closure of tracheoesophageal fistulas with primary chemotherapy in patients with esophageal cancer. Cancer 1994; 73: 1321-3.","DOI":"10.1002\/1097-0142(19940301)73:5<1321::AID-CNCR2820730502>3.0.CO;2-7"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39)Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, et al. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol 2008; 26: 4551-6.","DOI":"10.1200\/JCO.2008.16.6918"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1167"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41)Tachibana M, Dhar DK, Kinugasa S, Yoshimura H, Shibakita M, et al. Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus. Dysphagia 2002; 17: 255-61.","DOI":"10.1007\/s00455-002-0069-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42)Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, et al. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy followed by esophagectomy for T4 esophageal cancers. J Surg Oncol 2005; 90: 209-19.","DOI":"10.1002\/jso.20259"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43)Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, Coosemans W, et al. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 1997: 11: 828-37.","DOI":"10.1016\/S1010-7940(97)01194-9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44)Yano M, Shiozaki H, Tsujinaka T, Inoue M, Doki Y, et al. Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy. J Am Coll Surg 2000; 191: 626-34.","DOI":"10.1016\/S1072-7515(00)00757-2"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45)Bedenne L, Michel P, Bouch&eacute; O, Milan C, Mariette C, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-8.","DOI":"10.1200\/JCO.2005.04.7118"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T23:57:07Z","timestamp":1621555027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/atcs\/17\/3\/17_ra.11.01676\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.ra.11.01676","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}